nodes	percent_of_prediction	percent_of_DWPC	metapath
Ropivacaine—CYP2B6—Citalopram—alcohol dependence	0.176	0.356	CbGbCtD
Ropivacaine—CYP1A2—Citalopram—alcohol dependence	0.103	0.209	CbGbCtD
Ropivacaine—CYP2D6—Citalopram—alcohol dependence	0.0848	0.172	CbGbCtD
Ropivacaine—CYP3A4—Disulfiram—alcohol dependence	0.0757	0.154	CbGbCtD
Ropivacaine—CYP3A4—Citalopram—alcohol dependence	0.0539	0.109	CbGbCtD
Ropivacaine—SCN3A—spinal nerve—alcohol dependence	0.024	0.162	CbGeAlD
Ropivacaine—SCN8A—cerebellar cortex—alcohol dependence	0.0206	0.139	CbGeAlD
Ropivacaine—SCN8A—nerve—alcohol dependence	0.00757	0.0511	CbGeAlD
Ropivacaine—SCN10A—nerve—alcohol dependence	0.00507	0.0342	CbGeAlD
Ropivacaine—SCN8A—brainstem—alcohol dependence	0.00325	0.022	CbGeAlD
Ropivacaine—SCN8A—forebrain—alcohol dependence	0.00314	0.0212	CbGeAlD
Ropivacaine—CYP2D6—Fatty Acid Omega Oxidation—ADH6—alcohol dependence	0.00271	0.0309	CbGpPWpGaD
Ropivacaine—SCN1A—brainstem—alcohol dependence	0.00246	0.0166	CbGeAlD
Ropivacaine—SCN1A—forebrain—alcohol dependence	0.00237	0.016	CbGeAlD
Ropivacaine—CYP1A2—Fatty Acid Omega Oxidation—ADH6—alcohol dependence	0.00229	0.0262	CbGpPWpGaD
Ropivacaine—SCN2A—brainstem—alcohol dependence	0.00226	0.0152	CbGeAlD
Ropivacaine—CYP2D6—Fatty Acid Omega Oxidation—ADH1A—alcohol dependence	0.00224	0.0256	CbGpPWpGaD
Ropivacaine—SCN2A—forebrain—alcohol dependence	0.00218	0.0147	CbGeAlD
Ropivacaine—SCN10A—forebrain—alcohol dependence	0.0021	0.0142	CbGeAlD
Ropivacaine—SCN3A—forebrain—alcohol dependence	0.00191	0.0129	CbGeAlD
Ropivacaine—CYP2D6—Fatty Acid Omega Oxidation—ADH4—alcohol dependence	0.00191	0.0218	CbGpPWpGaD
Ropivacaine—CYP1A2—Fatty Acid Omega Oxidation—ADH1A—alcohol dependence	0.0019	0.0217	CbGpPWpGaD
Ropivacaine—SCN9A—midbrain—alcohol dependence	0.00182	0.0123	CbGeAlD
Ropivacaine—SCN8A—endocrine gland—alcohol dependence	0.00182	0.0123	CbGeAlD
Ropivacaine—CYP3A4—Fatty Acid Omega Oxidation—ADH6—alcohol dependence	0.00177	0.0202	CbGpPWpGaD
Ropivacaine—SCN8A—testis—alcohol dependence	0.00174	0.0117	CbGeAlD
Ropivacaine—SCN8A—nervous system—alcohol dependence	0.0017	0.0115	CbGeAlD
Ropivacaine—SCN8A—central nervous system—alcohol dependence	0.00164	0.0111	CbGeAlD
Ropivacaine—CYP2D6—Fatty Acid Omega Oxidation—ADH7—alcohol dependence	0.00162	0.0185	CbGpPWpGaD
Ropivacaine—CYP1A2—Fatty Acid Omega Oxidation—ADH4—alcohol dependence	0.00161	0.0184	CbGpPWpGaD
Ropivacaine—SCN5A—cardiovascular system—alcohol dependence	0.00161	0.0109	CbGeAlD
Ropivacaine—SCN8A—cerebellum—alcohol dependence	0.0016	0.0108	CbGeAlD
Ropivacaine—SCN1A—midbrain—alcohol dependence	0.00157	0.0106	CbGeAlD
Ropivacaine—CYP2B6—CYP2E1 reactions—CYP2E1—alcohol dependence	0.00155	0.0177	CbGpPWpGaD
Ropivacaine—SCN9A—testis—alcohol dependence	0.00152	0.0103	CbGeAlD
Ropivacaine—CYP3A4—Fatty Acid Omega Oxidation—ADH1A—alcohol dependence	0.00147	0.0167	CbGpPWpGaD
Ropivacaine—SCN2A—blood—alcohol dependence	0.00146	0.00983	CbGeAlD
Ropivacaine—SCN2A—midbrain—alcohol dependence	0.00144	0.00971	CbGeAlD
Ropivacaine—CYP2D6—Fatty Acid Omega Oxidation—ADH1B—alcohol dependence	0.00142	0.0162	CbGpPWpGaD
Ropivacaine—SCN10A—blood—alcohol dependence	0.0014	0.00948	CbGeAlD
Ropivacaine—CYP1A2—Fatty Acid Omega Oxidation—ADH7—alcohol dependence	0.00137	0.0157	CbGpPWpGaD
Ropivacaine—SCN4A—testis—alcohol dependence	0.00136	0.00919	CbGeAlD
Ropivacaine—SCN5A—digestive system—alcohol dependence	0.00134	0.00904	CbGeAlD
Ropivacaine—SCN4A—nervous system—alcohol dependence	0.00133	0.00902	CbGeAlD
Ropivacaine—Breast disorder—Acamprosate—alcohol dependence	0.00133	0.00489	CcSEcCtD
Ropivacaine—Hypocalcaemia—Citalopram—alcohol dependence	0.00133	0.00488	CcSEcCtD
Ropivacaine—Aspartate aminotransferase increased—Acamprosate—alcohol dependence	0.00132	0.00488	CcSEcCtD
Ropivacaine—Oliguria—Citalopram—alcohol dependence	0.00132	0.00485	CcSEcCtD
Ropivacaine—Paraesthesia—Disulfiram—alcohol dependence	0.00132	0.00485	CcSEcCtD
Ropivacaine—Somnolence—Disulfiram—alcohol dependence	0.0013	0.0048	CcSEcCtD
Ropivacaine—SCN8A—brain—alcohol dependence	0.0013	0.00879	CbGeAlD
Ropivacaine—Alanine aminotransferase increased—Acamprosate—alcohol dependence	0.0013	0.00478	CcSEcCtD
Ropivacaine—Dyskinesia—Citalopram—alcohol dependence	0.00129	0.00476	CcSEcCtD
Ropivacaine—Leukocytosis—Citalopram—alcohol dependence	0.00129	0.00476	CcSEcCtD
Ropivacaine—SCN1A—nervous system—alcohol dependence	0.00129	0.00869	CbGeAlD
Ropivacaine—SCN4A—central nervous system—alcohol dependence	0.00129	0.00868	CbGeAlD
Ropivacaine—Dysarthria—Citalopram—alcohol dependence	0.00128	0.00473	CcSEcCtD
Ropivacaine—SCN3A—blood—alcohol dependence	0.00128	0.00864	CbGeAlD
Ropivacaine—Abdominal distension—Acamprosate—alcohol dependence	0.00128	0.00471	CcSEcCtD
Ropivacaine—SCN5A—blood—alcohol dependence	0.00128	0.00861	CbGeAlD
Ropivacaine—SCN3A—midbrain—alcohol dependence	0.00126	0.00853	CbGeAlD
Ropivacaine—SCN2A—endocrine gland—alcohol dependence	0.00126	0.00853	CbGeAlD
Ropivacaine—Pain—Disulfiram—alcohol dependence	0.00125	0.00462	CcSEcCtD
Ropivacaine—Aspartate aminotransferase increased—Naltrexone—alcohol dependence	0.00125	0.00461	CcSEcCtD
Ropivacaine—Cramp muscle—Naltrexone—alcohol dependence	0.00125	0.00461	CcSEcCtD
Ropivacaine—CYP3A4—Fatty Acid Omega Oxidation—ADH4—alcohol dependence	0.00125	0.0142	CbGpPWpGaD
Ropivacaine—SCN1A—central nervous system—alcohol dependence	0.00124	0.00837	CbGeAlD
Ropivacaine—Muscle twitching—Citalopram—alcohol dependence	0.00124	0.00455	CcSEcCtD
Ropivacaine—Alanine aminotransferase increased—Naltrexone—alcohol dependence	0.00123	0.00452	CcSEcCtD
Ropivacaine—SCN10A—endocrine gland—alcohol dependence	0.00122	0.00822	CbGeAlD
Ropivacaine—Phosphatase alkaline increased—Citalopram—alcohol dependence	0.00121	0.00447	CcSEcCtD
Ropivacaine—Ventricular tachycardia—Citalopram—alcohol dependence	0.00121	0.00447	CcSEcCtD
Ropivacaine—Pulmonary embolism—Citalopram—alcohol dependence	0.00121	0.00447	CcSEcCtD
Ropivacaine—SCN1A—cerebellum—alcohol dependence	0.00121	0.00818	CbGeAlD
Ropivacaine—CYP1A2—Tryptophan metabolism—ALDH3A2—alcohol dependence	0.00121	0.0138	CbGpPWpGaD
Ropivacaine—CYP1A2—Fatty Acid Omega Oxidation—ADH1B—alcohol dependence	0.0012	0.0137	CbGpPWpGaD
Ropivacaine—SCN2A—nervous system—alcohol dependence	0.00118	0.00798	CbGeAlD
Ropivacaine—Urinary incontinence—Citalopram—alcohol dependence	0.00117	0.00432	CcSEcCtD
Ropivacaine—Nightmare—Citalopram—alcohol dependence	0.00117	0.00432	CcSEcCtD
Ropivacaine—Depressed level of consciousness—Citalopram—alcohol dependence	0.00117	0.00432	CcSEcCtD
Ropivacaine—Sweating increased—Naltrexone—alcohol dependence	0.00117	0.00431	CcSEcCtD
Ropivacaine—CYP1A2—Aflatoxin activation and detoxification—GGT2—alcohol dependence	0.00115	0.0131	CbGpPWpGaD
Ropivacaine—Hyperglycaemia—Acamprosate—alcohol dependence	0.00115	0.00422	CcSEcCtD
Ropivacaine—SCN9A—brain—alcohol dependence	0.00114	0.00773	CbGeAlD
Ropivacaine—SCN10A—nervous system—alcohol dependence	0.00114	0.0077	CbGeAlD
Ropivacaine—Neuropathy—Citalopram—alcohol dependence	0.00114	0.0042	CcSEcCtD
Ropivacaine—SCN2A—central nervous system—alcohol dependence	0.00114	0.00768	CbGeAlD
Ropivacaine—Depression—Acamprosate—alcohol dependence	0.00113	0.00416	CcSEcCtD
Ropivacaine—Acute coronary syndrome—Acamprosate—alcohol dependence	0.00112	0.00411	CcSEcCtD
Ropivacaine—SCN2A—cerebellum—alcohol dependence	0.00111	0.00751	CbGeAlD
Ropivacaine—Myocardial infarction—Acamprosate—alcohol dependence	0.00111	0.00409	CcSEcCtD
Ropivacaine—Coma—Citalopram—alcohol dependence	0.00111	0.00409	CcSEcCtD
Ropivacaine—Urinary tract infection—Acamprosate—alcohol dependence	0.0011	0.00406	CcSEcCtD
Ropivacaine—SCN10A—central nervous system—alcohol dependence	0.0011	0.00741	CbGeAlD
Ropivacaine—CYP2B6—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.0011	0.0125	CbGpPWpGaD
Ropivacaine—CYP2D6—CYP2E1 reactions—CYP2E1—alcohol dependence	0.00108	0.0123	CbGpPWpGaD
Ropivacaine—Haematuria—Acamprosate—alcohol dependence	0.00108	0.00398	CcSEcCtD
Ropivacaine—Depression—Naltrexone—alcohol dependence	0.00107	0.00394	CcSEcCtD
Ropivacaine—CYP3A4—Fatty Acid Omega Oxidation—ADH7—alcohol dependence	0.00106	0.0121	CbGpPWpGaD
Ropivacaine—SCN3A—testis—alcohol dependence	0.00106	0.00715	CbGeAlD
Ropivacaine—Acute coronary syndrome—Naltrexone—alcohol dependence	0.00106	0.00389	CcSEcCtD
Ropivacaine—Asthenia—Disulfiram—alcohol dependence	0.00105	0.00388	CcSEcCtD
Ropivacaine—Myocardial infarction—Naltrexone—alcohol dependence	0.00105	0.00387	CcSEcCtD
Ropivacaine—Urinary tract infection—Naltrexone—alcohol dependence	0.00104	0.00384	CcSEcCtD
Ropivacaine—SCN3A—nervous system—alcohol dependence	0.00104	0.00701	CbGeAlD
Ropivacaine—SCN5A—nervous system—alcohol dependence	0.00104	0.00699	CbGeAlD
Ropivacaine—Phlebitis—Citalopram—alcohol dependence	0.00102	0.00377	CcSEcCtD
Ropivacaine—SCN4A—brain—alcohol dependence	0.00102	0.00689	CbGeAlD
Ropivacaine—Rhinitis—Acamprosate—alcohol dependence	0.00102	0.00376	CcSEcCtD
Ropivacaine—Blood alkaline phosphatase increased—Citalopram—alcohol dependence	0.00101	0.00373	CcSEcCtD
Ropivacaine—Hallucination—Acamprosate—alcohol dependence	0.00101	0.00373	CcSEcCtD
Ropivacaine—Hypoaesthesia—Acamprosate—alcohol dependence	0.00101	0.00373	CcSEcCtD
Ropivacaine—CYP2D6—Fatty Acid Omega Oxidation—ALDH2—alcohol dependence	0.001	0.0114	CbGpPWpGaD
Ropivacaine—Oedema peripheral—Acamprosate—alcohol dependence	0.001	0.00369	CcSEcCtD
Ropivacaine—SCN3A—central nervous system—alcohol dependence	0.001	0.00675	CbGeAlD
Ropivacaine—SCN5A—central nervous system—alcohol dependence	0.000997	0.00673	CbGeAlD
Ropivacaine—Vascular purpura—Citalopram—alcohol dependence	0.000984	0.00363	CcSEcCtD
Ropivacaine—SCN1A—brain—alcohol dependence	0.000984	0.00665	CbGeAlD
Ropivacaine—SCN3A—cerebellum—alcohol dependence	0.000977	0.0066	CbGeAlD
Ropivacaine—Dizziness—Disulfiram—alcohol dependence	0.000969	0.00357	CcSEcCtD
Ropivacaine—CYP2B6—Xenobiotics—CYP2E1—alcohol dependence	0.000963	0.011	CbGpPWpGaD
Ropivacaine—Hallucination—Naltrexone—alcohol dependence	0.000957	0.00353	CcSEcCtD
Ropivacaine—Tinnitus—Acamprosate—alcohol dependence	0.000948	0.00349	CcSEcCtD
Ropivacaine—Amnesia—Citalopram—alcohol dependence	0.000937	0.00346	CcSEcCtD
Ropivacaine—CYP3A4—Tryptophan metabolism—ALDH3A2—alcohol dependence	0.000932	0.0106	CbGpPWpGaD
Ropivacaine—Atrial fibrillation—Citalopram—alcohol dependence	0.000929	0.00343	CcSEcCtD
Ropivacaine—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—alcohol dependence	0.000929	0.0106	CbGpPWpGaD
Ropivacaine—Rash—Disulfiram—alcohol dependence	0.000924	0.00341	CcSEcCtD
Ropivacaine—Headache—Disulfiram—alcohol dependence	0.000918	0.00338	CcSEcCtD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—ALDH3A1—alcohol dependence	0.000915	0.0105	CbGpPWpGaD
Ropivacaine—Purpura—Citalopram—alcohol dependence	0.000914	0.00337	CcSEcCtD
Ropivacaine—Chills—Acamprosate—alcohol dependence	0.000912	0.00336	CcSEcCtD
Ropivacaine—CYP2B6—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000908	0.0104	CbGpPWpGaD
Ropivacaine—SCN2A—brain—alcohol dependence	0.000903	0.0061	CbGeAlD
Ropivacaine—Hypoglycaemia—Citalopram—alcohol dependence	0.000902	0.00333	CcSEcCtD
Ropivacaine—Tinnitus—Naltrexone—alcohol dependence	0.000897	0.0033	CcSEcCtD
Ropivacaine—Cardiac disorder—Naltrexone—alcohol dependence	0.000892	0.00329	CcSEcCtD
Ropivacaine—CYP2B6—adrenal cortex—alcohol dependence	0.000892	0.00602	CbGeAlD
Ropivacaine—Mental disorder—Acamprosate—alcohol dependence	0.00089	0.00328	CcSEcCtD
Ropivacaine—CYP3A4—Aflatoxin activation and detoxification—GGT2—alcohol dependence	0.000885	0.0101	CbGpPWpGaD
Ropivacaine—Osteoarthritis—Citalopram—alcohol dependence	0.000881	0.00325	CcSEcCtD
Ropivacaine—SCN10A—brain—alcohol dependence	0.000871	0.00588	CbGeAlD
Ropivacaine—Tension—Acamprosate—alcohol dependence	0.000868	0.0032	CcSEcCtD
Ropivacaine—Affect lability—Citalopram—alcohol dependence	0.000867	0.0032	CcSEcCtD
Ropivacaine—Chills—Naltrexone—alcohol dependence	0.000863	0.00318	CcSEcCtD
Ropivacaine—Nervousness—Acamprosate—alcohol dependence	0.000859	0.00317	CcSEcCtD
Ropivacaine—Back pain—Acamprosate—alcohol dependence	0.000856	0.00315	CcSEcCtD
Ropivacaine—Muscle spasms—Acamprosate—alcohol dependence	0.000851	0.00314	CcSEcCtD
Ropivacaine—CYP1A2—Fatty Acid Omega Oxidation—ALDH2—alcohol dependence	0.000848	0.00968	CbGpPWpGaD
Ropivacaine—Mental disorder—Naltrexone—alcohol dependence	0.000842	0.00311	CcSEcCtD
Ropivacaine—Cardiac arrest—Citalopram—alcohol dependence	0.000837	0.00309	CcSEcCtD
Ropivacaine—Urinary retention—Citalopram—alcohol dependence	0.000837	0.00309	CcSEcCtD
Ropivacaine—Mood swings—Citalopram—alcohol dependence	0.000834	0.00308	CcSEcCtD
Ropivacaine—Tremor—Acamprosate—alcohol dependence	0.000829	0.00306	CcSEcCtD
Ropivacaine—Tension—Naltrexone—alcohol dependence	0.000821	0.00303	CcSEcCtD
Ropivacaine—Ill-defined disorder—Acamprosate—alcohol dependence	0.000821	0.00303	CcSEcCtD
Ropivacaine—Anaemia—Acamprosate—alcohol dependence	0.000818	0.00301	CcSEcCtD
Ropivacaine—CYP2B6—cardiovascular system—alcohol dependence	0.000814	0.0055	CbGeAlD
Ropivacaine—Agitation—Acamprosate—alcohol dependence	0.000813	0.003	CcSEcCtD
Ropivacaine—Nervousness—Naltrexone—alcohol dependence	0.000813	0.003	CcSEcCtD
Ropivacaine—Back pain—Naltrexone—alcohol dependence	0.00081	0.00298	CcSEcCtD
Ropivacaine—Angioedema—Acamprosate—alcohol dependence	0.000808	0.00298	CcSEcCtD
Ropivacaine—Muscle spasms—Naltrexone—alcohol dependence	0.000805	0.00297	CcSEcCtD
Ropivacaine—Orthostatic hypotension—Citalopram—alcohol dependence	0.000804	0.00296	CcSEcCtD
Ropivacaine—Hypokalaemia—Citalopram—alcohol dependence	0.000801	0.00295	CcSEcCtD
Ropivacaine—CYP2D6—Fatty Acid Omega Oxidation—CYP2E1—alcohol dependence	0.0008	0.00914	CbGpPWpGaD
Ropivacaine—Malaise—Acamprosate—alcohol dependence	0.000798	0.00294	CcSEcCtD
Ropivacaine—Breast disorder—Citalopram—alcohol dependence	0.000796	0.00293	CcSEcCtD
Ropivacaine—Vertigo—Acamprosate—alcohol dependence	0.000795	0.00293	CcSEcCtD
Ropivacaine—SCN3A—brain—alcohol dependence	0.000794	0.00536	CbGeAlD
Ropivacaine—Syncope—Acamprosate—alcohol dependence	0.000793	0.00292	CcSEcCtD
Ropivacaine—Aspartate aminotransferase increased—Citalopram—alcohol dependence	0.000793	0.00292	CcSEcCtD
Ropivacaine—Cramp muscle—Citalopram—alcohol dependence	0.000793	0.00292	CcSEcCtD
Ropivacaine—SCN5A—brain—alcohol dependence	0.000791	0.00535	CbGeAlD
Ropivacaine—Vision blurred—Naltrexone—alcohol dependence	0.000789	0.00291	CcSEcCtD
Ropivacaine—Tremor—Naltrexone—alcohol dependence	0.000784	0.00289	CcSEcCtD
Ropivacaine—Loss of consciousness—Acamprosate—alcohol dependence	0.000778	0.00287	CcSEcCtD
Ropivacaine—Alanine aminotransferase increased—Citalopram—alcohol dependence	0.000777	0.00286	CcSEcCtD
Ropivacaine—Ill-defined disorder—Naltrexone—alcohol dependence	0.000777	0.00286	CcSEcCtD
Ropivacaine—CYP2B6—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000772	0.00882	CbGpPWpGaD
Ropivacaine—Cough—Acamprosate—alcohol dependence	0.000772	0.00285	CcSEcCtD
Ropivacaine—Agitation—Naltrexone—alcohol dependence	0.000769	0.00284	CcSEcCtD
Ropivacaine—Convulsion—Acamprosate—alcohol dependence	0.000767	0.00283	CcSEcCtD
Ropivacaine—Abdominal distension—Citalopram—alcohol dependence	0.000766	0.00282	CcSEcCtD
Ropivacaine—Angioedema—Naltrexone—alcohol dependence	0.000765	0.00282	CcSEcCtD
Ropivacaine—Hypertension—Acamprosate—alcohol dependence	0.000764	0.00282	CcSEcCtD
Ropivacaine—CYP2D6—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.000762	0.0087	CbGpPWpGaD
Ropivacaine—Malaise—Naltrexone—alcohol dependence	0.000755	0.00278	CcSEcCtD
Ropivacaine—Myalgia—Acamprosate—alcohol dependence	0.000753	0.00278	CcSEcCtD
Ropivacaine—Chest pain—Acamprosate—alcohol dependence	0.000753	0.00278	CcSEcCtD
Ropivacaine—Arthralgia—Acamprosate—alcohol dependence	0.000753	0.00278	CcSEcCtD
Ropivacaine—Syncope—Naltrexone—alcohol dependence	0.000751	0.00277	CcSEcCtD
Ropivacaine—Anxiety—Acamprosate—alcohol dependence	0.000751	0.00277	CcSEcCtD
Ropivacaine—Bronchospasm—Citalopram—alcohol dependence	0.000749	0.00276	CcSEcCtD
Ropivacaine—Discomfort—Acamprosate—alcohol dependence	0.000744	0.00274	CcSEcCtD
Ropivacaine—Sweating increased—Citalopram—alcohol dependence	0.000741	0.00273	CcSEcCtD
Ropivacaine—CYP2D6—brainstem—alcohol dependence	0.000741	0.00501	CbGeAlD
Ropivacaine—CYP2B6—gonad—alcohol dependence	0.000739	0.00499	CbGeAlD
Ropivacaine—Loss of consciousness—Naltrexone—alcohol dependence	0.000736	0.00271	CcSEcCtD
Ropivacaine—Cough—Naltrexone—alcohol dependence	0.00073	0.00269	CcSEcCtD
Ropivacaine—Confusional state—Acamprosate—alcohol dependence	0.000728	0.00268	CcSEcCtD
Ropivacaine—Convulsion—Naltrexone—alcohol dependence	0.000725	0.00267	CcSEcCtD
Ropivacaine—Hypertension—Naltrexone—alcohol dependence	0.000723	0.00266	CcSEcCtD
Ropivacaine—Anaphylactic shock—Acamprosate—alcohol dependence	0.000722	0.00266	CcSEcCtD
Ropivacaine—Infection—Acamprosate—alcohol dependence	0.000717	0.00264	CcSEcCtD
Ropivacaine—CYP2D6—forebrain—alcohol dependence	0.000715	0.00483	CbGeAlD
Ropivacaine—Myalgia—Naltrexone—alcohol dependence	0.000713	0.00263	CcSEcCtD
Ropivacaine—Chest pain—Naltrexone—alcohol dependence	0.000713	0.00263	CcSEcCtD
Ropivacaine—Arthralgia—Naltrexone—alcohol dependence	0.000713	0.00263	CcSEcCtD
Ropivacaine—Dysuria—Citalopram—alcohol dependence	0.000712	0.00262	CcSEcCtD
Ropivacaine—Shock—Acamprosate—alcohol dependence	0.00071	0.00262	CcSEcCtD
Ropivacaine—Anxiety—Naltrexone—alcohol dependence	0.00071	0.00262	CcSEcCtD
Ropivacaine—Thrombocytopenia—Acamprosate—alcohol dependence	0.000707	0.00261	CcSEcCtD
Ropivacaine—CYP1A2—digestive system—alcohol dependence	0.000705	0.00476	CbGeAlD
Ropivacaine—Tachycardia—Acamprosate—alcohol dependence	0.000705	0.0026	CcSEcCtD
Ropivacaine—Discomfort—Naltrexone—alcohol dependence	0.000704	0.0026	CcSEcCtD
Ropivacaine—Skin disorder—Acamprosate—alcohol dependence	0.000701	0.00259	CcSEcCtD
Ropivacaine—Hyperhidrosis—Acamprosate—alcohol dependence	0.000698	0.00257	CcSEcCtD
Ropivacaine—Confusional state—Naltrexone—alcohol dependence	0.000689	0.00254	CcSEcCtD
Ropivacaine—Hyperglycaemia—Citalopram—alcohol dependence	0.000687	0.00253	CcSEcCtD
Ropivacaine—Anaphylactic shock—Naltrexone—alcohol dependence	0.000683	0.00252	CcSEcCtD
Ropivacaine—Infection—Naltrexone—alcohol dependence	0.000679	0.0025	CcSEcCtD
Ropivacaine—CYP1A2—Fatty Acid Omega Oxidation—CYP2E1—alcohol dependence	0.000678	0.00774	CbGpPWpGaD
Ropivacaine—Depression—Citalopram—alcohol dependence	0.000677	0.00249	CcSEcCtD
Ropivacaine—CYP2B6—digestive system—alcohol dependence	0.000676	0.00456	CbGeAlD
Ropivacaine—Hypotension—Acamprosate—alcohol dependence	0.000675	0.00249	CcSEcCtD
Ropivacaine—Shock—Naltrexone—alcohol dependence	0.000672	0.00248	CcSEcCtD
Ropivacaine—CYP1A2—blood—alcohol dependence	0.000671	0.00454	CbGeAlD
Ropivacaine—CYP2D6—Xenobiotics—CYP2E1—alcohol dependence	0.00067	0.00764	CbGpPWpGaD
Ropivacaine—Acute coronary syndrome—Citalopram—alcohol dependence	0.000669	0.00247	CcSEcCtD
Ropivacaine—Tachycardia—Naltrexone—alcohol dependence	0.000667	0.00246	CcSEcCtD
Ropivacaine—Neuropathy peripheral—Citalopram—alcohol dependence	0.000665	0.00245	CcSEcCtD
Ropivacaine—Myocardial infarction—Citalopram—alcohol dependence	0.000665	0.00245	CcSEcCtD
Ropivacaine—Skin disorder—Naltrexone—alcohol dependence	0.000664	0.00245	CcSEcCtD
Ropivacaine—Jaundice—Citalopram—alcohol dependence	0.000662	0.00244	CcSEcCtD
Ropivacaine—Hyperhidrosis—Naltrexone—alcohol dependence	0.00066	0.00243	CcSEcCtD
Ropivacaine—Urinary tract infection—Citalopram—alcohol dependence	0.00066	0.00243	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.000658	0.00242	CcSEcCtD
Ropivacaine—CYP2B6—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000657	0.0075	CbGpPWpGaD
Ropivacaine—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—alcohol dependence	0.000655	0.00747	CbGpPWpGaD
Ropivacaine—Insomnia—Acamprosate—alcohol dependence	0.000653	0.00241	CcSEcCtD
Ropivacaine—Paraesthesia—Acamprosate—alcohol dependence	0.000648	0.00239	CcSEcCtD
Ropivacaine—Haematuria—Citalopram—alcohol dependence	0.000647	0.00239	CcSEcCtD
Ropivacaine—CYP1A2—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.000645	0.00737	CbGpPWpGaD
Ropivacaine—CYP2D6—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.000644	0.00735	CbGpPWpGaD
Ropivacaine—Dyspnoea—Acamprosate—alcohol dependence	0.000644	0.00237	CcSEcCtD
Ropivacaine—CYP2B6—blood—alcohol dependence	0.000644	0.00435	CbGeAlD
Ropivacaine—Somnolence—Acamprosate—alcohol dependence	0.000642	0.00237	CcSEcCtD
Ropivacaine—Dyspepsia—Acamprosate—alcohol dependence	0.000636	0.00234	CcSEcCtD
Ropivacaine—CYP2D6—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000631	0.00721	CbGpPWpGaD
Ropivacaine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.00063	0.00719	CbGpPWpGaD
Ropivacaine—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.000622	0.00229	CcSEcCtD
Ropivacaine—Bradycardia—Citalopram—alcohol dependence	0.00062	0.00229	CcSEcCtD
Ropivacaine—Insomnia—Naltrexone—alcohol dependence	0.000618	0.00228	CcSEcCtD
Ropivacaine—Pain—Acamprosate—alcohol dependence	0.000617	0.00228	CcSEcCtD
Ropivacaine—Constipation—Acamprosate—alcohol dependence	0.000617	0.00228	CcSEcCtD
Ropivacaine—Paraesthesia—Naltrexone—alcohol dependence	0.000613	0.00226	CcSEcCtD
Ropivacaine—Rhinitis—Citalopram—alcohol dependence	0.000611	0.00225	CcSEcCtD
Ropivacaine—Dyspnoea—Naltrexone—alcohol dependence	0.000609	0.00224	CcSEcCtD
Ropivacaine—Somnolence—Naltrexone—alcohol dependence	0.000607	0.00224	CcSEcCtD
Ropivacaine—Hallucination—Citalopram—alcohol dependence	0.000606	0.00223	CcSEcCtD
Ropivacaine—Hypoaesthesia—Citalopram—alcohol dependence	0.000606	0.00223	CcSEcCtD
Ropivacaine—Urinary tract disorder—Citalopram—alcohol dependence	0.000602	0.00222	CcSEcCtD
Ropivacaine—Oedema peripheral—Citalopram—alcohol dependence	0.0006	0.00221	CcSEcCtD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—CHRM2—alcohol dependence	0.0006	0.00685	CbGpPWpGaD
Ropivacaine—Urethral disorder—Citalopram—alcohol dependence	0.000597	0.0022	CcSEcCtD
Ropivacaine—Feeling abnormal—Acamprosate—alcohol dependence	0.000595	0.00219	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Acamprosate—alcohol dependence	0.00059	0.00218	CcSEcCtD
Ropivacaine—Pain—Naltrexone—alcohol dependence	0.000584	0.00215	CcSEcCtD
Ropivacaine—Constipation—Naltrexone—alcohol dependence	0.000584	0.00215	CcSEcCtD
Ropivacaine—CYP1A2—endocrine gland—alcohol dependence	0.000582	0.00393	CbGeAlD
Ropivacaine—CYP2B6—Biological oxidations—ADH6—alcohol dependence	0.000582	0.00665	CbGpPWpGaD
Ropivacaine—CYP2B6—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000576	0.00657	CbGpPWpGaD
Ropivacaine—Urticaria—Acamprosate—alcohol dependence	0.000574	0.00211	CcSEcCtD
Ropivacaine—Body temperature increased—Acamprosate—alcohol dependence	0.000571	0.0021	CcSEcCtD
Ropivacaine—Abdominal pain—Acamprosate—alcohol dependence	0.000571	0.0021	CcSEcCtD
Ropivacaine—Tinnitus—Citalopram—alcohol dependence	0.000568	0.00209	CcSEcCtD
Ropivacaine—CYP1A2—Xenobiotics—CYP2E1—alcohol dependence	0.000567	0.00648	CbGpPWpGaD
Ropivacaine—Cardiac disorder—Citalopram—alcohol dependence	0.000565	0.00208	CcSEcCtD
Ropivacaine—Feeling abnormal—Naltrexone—alcohol dependence	0.000563	0.00208	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Naltrexone—alcohol dependence	0.000559	0.00206	CcSEcCtD
Ropivacaine—CYP2B6—endocrine gland—alcohol dependence	0.000558	0.00377	CbGeAlD
Ropivacaine—Chills—Citalopram—alcohol dependence	0.000547	0.00201	CcSEcCtD
Ropivacaine—CYP1A2—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.000546	0.00623	CbGpPWpGaD
Ropivacaine—Arrhythmia—Citalopram—alcohol dependence	0.000544	0.00201	CcSEcCtD
Ropivacaine—Urticaria—Naltrexone—alcohol dependence	0.000543	0.002	CcSEcCtD
Ropivacaine—CYP1A2—Aflatoxin activation and detoxification—GGT1—alcohol dependence	0.000543	0.00619	CbGpPWpGaD
Ropivacaine—Abdominal pain—Naltrexone—alcohol dependence	0.00054	0.00199	CcSEcCtD
Ropivacaine—Body temperature increased—Naltrexone—alcohol dependence	0.00054	0.00199	CcSEcCtD
Ropivacaine—CYP2D6—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000537	0.00613	CbGpPWpGaD
Ropivacaine—CYP1A2—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000535	0.00611	CbGpPWpGaD
Ropivacaine—Mental disorder—Citalopram—alcohol dependence	0.000534	0.00197	CcSEcCtD
Ropivacaine—CYP2B6—testis—alcohol dependence	0.000532	0.0036	CbGeAlD
Ropivacaine—Hypersensitivity—Acamprosate—alcohol dependence	0.000532	0.00196	CcSEcCtD
Ropivacaine—Erythema—Citalopram—alcohol dependence	0.00053	0.00195	CcSEcCtD
Ropivacaine—CYP1A2—liver—alcohol dependence	0.000525	0.00355	CbGeAlD
Ropivacaine—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—alcohol dependence	0.000523	0.00597	CbGpPWpGaD
Ropivacaine—CYP2B6—nervous system—alcohol dependence	0.000522	0.00353	CbGeAlD
Ropivacaine—Tension—Citalopram—alcohol dependence	0.00052	0.00192	CcSEcCtD
Ropivacaine—Asthenia—Acamprosate—alcohol dependence	0.000518	0.00191	CcSEcCtD
Ropivacaine—Nervousness—Citalopram—alcohol dependence	0.000515	0.0019	CcSEcCtD
Ropivacaine—Back pain—Citalopram—alcohol dependence	0.000513	0.00189	CcSEcCtD
Ropivacaine—Pruritus—Acamprosate—alcohol dependence	0.000511	0.00188	CcSEcCtD
Ropivacaine—CYP3A4—digestive system—alcohol dependence	0.00051	0.00345	CbGeAlD
Ropivacaine—Muscle spasms—Citalopram—alcohol dependence	0.00051	0.00188	CcSEcCtD
Ropivacaine—CYP2B6—liver—alcohol dependence	0.000503	0.0034	CbGeAlD
Ropivacaine—Hypersensitivity—Naltrexone—alcohol dependence	0.000503	0.00186	CcSEcCtD
Ropivacaine—CYP2B6—central nervous system—alcohol dependence	0.000503	0.0034	CbGeAlD
Ropivacaine—CYP2D6—digestive system—alcohol dependence	0.000502	0.00339	CbGeAlD
Ropivacaine—Vision blurred—Citalopram—alcohol dependence	0.0005	0.00184	CcSEcCtD
Ropivacaine—CYP3A4—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.000498	0.00569	CbGpPWpGaD
Ropivacaine—Tremor—Citalopram—alcohol dependence	0.000497	0.00183	CcSEcCtD
Ropivacaine—Diarrhoea—Acamprosate—alcohol dependence	0.000494	0.00182	CcSEcCtD
Ropivacaine—Ill-defined disorder—Citalopram—alcohol dependence	0.000492	0.00181	CcSEcCtD
Ropivacaine—Anaemia—Citalopram—alcohol dependence	0.00049	0.00181	CcSEcCtD
Ropivacaine—Asthenia—Naltrexone—alcohol dependence	0.00049	0.00181	CcSEcCtD
Ropivacaine—Agitation—Citalopram—alcohol dependence	0.000487	0.0018	CcSEcCtD
Ropivacaine—CYP3A4—blood—alcohol dependence	0.000486	0.00328	CbGeAlD
Ropivacaine—Angioedema—Citalopram—alcohol dependence	0.000485	0.00179	CcSEcCtD
Ropivacaine—Pruritus—Naltrexone—alcohol dependence	0.000483	0.00178	CcSEcCtD
Ropivacaine—CYP2B6—Biological oxidations—ADH1A—alcohol dependence	0.000482	0.00551	CbGpPWpGaD
Ropivacaine—Malaise—Citalopram—alcohol dependence	0.000478	0.00176	CcSEcCtD
Ropivacaine—CYP2D6—blood—alcohol dependence	0.000478	0.00323	CbGeAlD
Ropivacaine—Dizziness—Acamprosate—alcohol dependence	0.000477	0.00176	CcSEcCtD
Ropivacaine—CYP2B6—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000477	0.00545	CbGpPWpGaD
Ropivacaine—Vertigo—Citalopram—alcohol dependence	0.000476	0.00176	CcSEcCtD
Ropivacaine—Syncope—Citalopram—alcohol dependence	0.000476	0.00175	CcSEcCtD
Ropivacaine—Diarrhoea—Naltrexone—alcohol dependence	0.000467	0.00172	CcSEcCtD
Ropivacaine—Loss of consciousness—Citalopram—alcohol dependence	0.000466	0.00172	CcSEcCtD
Ropivacaine—Cough—Citalopram—alcohol dependence	0.000463	0.00171	CcSEcCtD
Ropivacaine—Convulsion—Citalopram—alcohol dependence	0.00046	0.00169	CcSEcCtD
Ropivacaine—Vomiting—Acamprosate—alcohol dependence	0.000459	0.00169	CcSEcCtD
Ropivacaine—Hypertension—Citalopram—alcohol dependence	0.000458	0.00169	CcSEcCtD
Ropivacaine—CYP2D6—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000456	0.00521	CbGpPWpGaD
Ropivacaine—Rash—Acamprosate—alcohol dependence	0.000455	0.00168	CcSEcCtD
Ropivacaine—Dermatitis—Acamprosate—alcohol dependence	0.000455	0.00168	CcSEcCtD
Ropivacaine—CYP1A2—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000455	0.00519	CbGpPWpGaD
Ropivacaine—SCN8A—Axon guidance—GRIN2B—alcohol dependence	0.000455	0.00519	CbGpPWpGaD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—SLC6A4—alcohol dependence	0.000455	0.00519	CbGpPWpGaD
Ropivacaine—Headache—Acamprosate—alcohol dependence	0.000452	0.00167	CcSEcCtD
Ropivacaine—Dizziness—Naltrexone—alcohol dependence	0.000452	0.00167	CcSEcCtD
Ropivacaine—Myalgia—Citalopram—alcohol dependence	0.000452	0.00166	CcSEcCtD
Ropivacaine—Arthralgia—Citalopram—alcohol dependence	0.000452	0.00166	CcSEcCtD
Ropivacaine—Chest pain—Citalopram—alcohol dependence	0.000452	0.00166	CcSEcCtD
Ropivacaine—Anxiety—Citalopram—alcohol dependence	0.00045	0.00166	CcSEcCtD
Ropivacaine—Discomfort—Citalopram—alcohol dependence	0.000446	0.00164	CcSEcCtD
Ropivacaine—CYP3A4—Xenobiotics—CYP2E1—alcohol dependence	0.000438	0.005	CbGpPWpGaD
Ropivacaine—Confusional state—Citalopram—alcohol dependence	0.000436	0.00161	CcSEcCtD
Ropivacaine—Vomiting—Naltrexone—alcohol dependence	0.000434	0.0016	CcSEcCtD
Ropivacaine—Anaphylactic shock—Citalopram—alcohol dependence	0.000433	0.0016	CcSEcCtD
Ropivacaine—Rash—Naltrexone—alcohol dependence	0.000431	0.00159	CcSEcCtD
Ropivacaine—Dermatitis—Naltrexone—alcohol dependence	0.00043	0.00159	CcSEcCtD
Ropivacaine—Infection—Citalopram—alcohol dependence	0.00043	0.00159	CcSEcCtD
Ropivacaine—Nausea—Acamprosate—alcohol dependence	0.000429	0.00158	CcSEcCtD
Ropivacaine—CYP1A2—Tryptophan metabolism—MAOB—alcohol dependence	0.000429	0.00489	CbGpPWpGaD
Ropivacaine—Headache—Naltrexone—alcohol dependence	0.000428	0.00158	CcSEcCtD
Ropivacaine—Shock—Citalopram—alcohol dependence	0.000426	0.00157	CcSEcCtD
Ropivacaine—Thrombocytopenia—Citalopram—alcohol dependence	0.000424	0.00156	CcSEcCtD
Ropivacaine—Tachycardia—Citalopram—alcohol dependence	0.000422	0.00156	CcSEcCtD
Ropivacaine—CYP3A4—endocrine gland—alcohol dependence	0.000422	0.00285	CbGeAlD
Ropivacaine—CYP3A4—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.000421	0.00481	CbGpPWpGaD
Ropivacaine—Skin disorder—Citalopram—alcohol dependence	0.00042	0.00155	CcSEcCtD
Ropivacaine—CYP3A4—Aflatoxin activation and detoxification—GGT1—alcohol dependence	0.000419	0.00478	CbGpPWpGaD
Ropivacaine—Hyperhidrosis—Citalopram—alcohol dependence	0.000418	0.00154	CcSEcCtD
Ropivacaine—CYP2D6—endocrine gland—alcohol dependence	0.000415	0.0028	CbGeAlD
Ropivacaine—CYP3A4—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000413	0.00471	CbGpPWpGaD
Ropivacaine—CYP2B6—Biological oxidations—ADH4—alcohol dependence	0.00041	0.00468	CbGpPWpGaD
Ropivacaine—CYP2D6—Melatonin metabolism and effects—MAOA—alcohol dependence	0.000409	0.00467	CbGpPWpGaD
Ropivacaine—Nausea—Naltrexone—alcohol dependence	0.000406	0.0015	CcSEcCtD
Ropivacaine—CYP2B6—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000406	0.00463	CbGpPWpGaD
Ropivacaine—CYP2D6—Biological oxidations—ADH6—alcohol dependence	0.000405	0.00462	CbGpPWpGaD
Ropivacaine—Hypotension—Citalopram—alcohol dependence	0.000404	0.00149	CcSEcCtD
Ropivacaine—CYP2D6—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.0004	0.00457	CbGpPWpGaD
Ropivacaine—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.0004	0.00457	CbGpPWpGaD
Ropivacaine—CYP2B6—brain—alcohol dependence	0.000399	0.0027	CbGeAlD
Ropivacaine—CYP2D6—testis—alcohol dependence	0.000396	0.00267	CbGeAlD
Ropivacaine—CYP2B6—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000395	0.00451	CbGpPWpGaD
Ropivacaine—CYP3A4—nervous system—alcohol dependence	0.000395	0.00266	CbGeAlD
Ropivacaine—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.000394	0.00145	CcSEcCtD
Ropivacaine—Insomnia—Citalopram—alcohol dependence	0.000391	0.00144	CcSEcCtD
Ropivacaine—Paraesthesia—Citalopram—alcohol dependence	0.000389	0.00143	CcSEcCtD
Ropivacaine—CYP2D6—nervous system—alcohol dependence	0.000388	0.00262	CbGeAlD
Ropivacaine—CYP1A2—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000387	0.00441	CbGpPWpGaD
Ropivacaine—Dyspnoea—Citalopram—alcohol dependence	0.000386	0.00142	CcSEcCtD
Ropivacaine—Somnolence—Citalopram—alcohol dependence	0.000385	0.00142	CcSEcCtD
Ropivacaine—Dyspepsia—Citalopram—alcohol dependence	0.000381	0.0014	CcSEcCtD
Ropivacaine—CYP3A4—liver—alcohol dependence	0.00038	0.00257	CbGeAlD
Ropivacaine—CYP3A4—central nervous system—alcohol dependence	0.00038	0.00257	CbGeAlD
Ropivacaine—CYP2D6—liver—alcohol dependence	0.000374	0.00253	CbGeAlD
Ropivacaine—CYP2D6—central nervous system—alcohol dependence	0.000374	0.00252	CbGeAlD
Ropivacaine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000371	0.00424	CbGpPWpGaD
Ropivacaine—Constipation—Citalopram—alcohol dependence	0.00037	0.00136	CcSEcCtD
Ropivacaine—Pain—Citalopram—alcohol dependence	0.00037	0.00136	CcSEcCtD
Ropivacaine—SCN9A—Axon guidance—GRIN2B—alcohol dependence	0.000368	0.0042	CbGpPWpGaD
Ropivacaine—CYP2D6—cerebellum—alcohol dependence	0.000365	0.00247	CbGeAlD
Ropivacaine—CYP1A2—Tryptophan metabolism—ALDH2—alcohol dependence	0.000364	0.00416	CbGpPWpGaD
Ropivacaine—Feeling abnormal—Citalopram—alcohol dependence	0.000357	0.00131	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Citalopram—alcohol dependence	0.000354	0.0013	CcSEcCtD
Ropivacaine—SCN3A—Axon guidance—GRIN2B—alcohol dependence	0.000352	0.00402	CbGpPWpGaD
Ropivacaine—CYP3A4—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000351	0.00401	CbGpPWpGaD
Ropivacaine—CYP2B6—Biological oxidations—ADH7—alcohol dependence	0.000349	0.00398	CbGpPWpGaD
Ropivacaine—CYP1A2—Melatonin metabolism and effects—MAOA—alcohol dependence	0.000347	0.00396	CbGpPWpGaD
Ropivacaine—Urticaria—Citalopram—alcohol dependence	0.000344	0.00127	CcSEcCtD
Ropivacaine—CYP1A2—Biological oxidations—ADH6—alcohol dependence	0.000343	0.00391	CbGpPWpGaD
Ropivacaine—Abdominal pain—Citalopram—alcohol dependence	0.000342	0.00126	CcSEcCtD
Ropivacaine—Body temperature increased—Citalopram—alcohol dependence	0.000342	0.00126	CcSEcCtD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—MAOA—alcohol dependence	0.000342	0.0039	CbGpPWpGaD
Ropivacaine—CYP1A2—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000339	0.00387	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—GRIN2B—alcohol dependence	0.000338	0.00386	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—GRIN2B—alcohol dependence	0.000338	0.00386	CbGpPWpGaD
Ropivacaine—CYP1A2—Phase II conjugation—GGT2—alcohol dependence	0.000337	0.00384	CbGpPWpGaD
Ropivacaine—CYP2D6—Biological oxidations—ADH1A—alcohol dependence	0.000335	0.00383	CbGpPWpGaD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—AVP—alcohol dependence	0.000335	0.00383	CbGpPWpGaD
Ropivacaine—CYP2B6—Biological oxidations—GGT2—alcohol dependence	0.000334	0.00382	CbGpPWpGaD
Ropivacaine—CYP2D6—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000332	0.00379	CbGpPWpGaD
Ropivacaine—CYP3A4—Tryptophan metabolism—MAOB—alcohol dependence	0.000331	0.00378	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—GRIN2B—alcohol dependence	0.000326	0.00372	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—GRIN2B—alcohol dependence	0.000326	0.00372	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—GRIN2B—alcohol dependence	0.000324	0.0037	CbGpPWpGaD
Ropivacaine—CYP2B6—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000324	0.0037	CbGpPWpGaD
Ropivacaine—Hypersensitivity—Citalopram—alcohol dependence	0.000319	0.00118	CcSEcCtD
Ropivacaine—Asthenia—Citalopram—alcohol dependence	0.000311	0.00114	CcSEcCtD
Ropivacaine—Pruritus—Citalopram—alcohol dependence	0.000306	0.00113	CcSEcCtD
Ropivacaine—CYP2B6—Biological oxidations—ADH1B—alcohol dependence	0.000306	0.00349	CbGpPWpGaD
Ropivacaine—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000298	0.00341	CbGpPWpGaD
Ropivacaine—CYP2D6—brain—alcohol dependence	0.000297	0.002	CbGeAlD
Ropivacaine—Diarrhoea—Citalopram—alcohol dependence	0.000296	0.00109	CcSEcCtD
Ropivacaine—CYP1A2—Tryptophan metabolism—CYP2E1—alcohol dependence	0.000291	0.00333	CbGpPWpGaD
Ropivacaine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000286	0.00327	CbGpPWpGaD
Ropivacaine—Dizziness—Citalopram—alcohol dependence	0.000286	0.00106	CcSEcCtD
Ropivacaine—CYP2D6—Biological oxidations—ADH4—alcohol dependence	0.000285	0.00325	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—ADH1A—alcohol dependence	0.000284	0.00324	CbGpPWpGaD
Ropivacaine—CYP2D6—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000282	0.00322	CbGpPWpGaD
Ropivacaine—CYP3A4—Tryptophan metabolism—ALDH2—alcohol dependence	0.000281	0.00321	CbGpPWpGaD
Ropivacaine—CYP1A2—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000281	0.00321	CbGpPWpGaD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—HTR2A—alcohol dependence	0.000279	0.00318	CbGpPWpGaD
Ropivacaine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000278	0.00317	CbGpPWpGaD
Ropivacaine—Vomiting—Citalopram—alcohol dependence	0.000275	0.00101	CcSEcCtD
Ropivacaine—CYP2D6—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000274	0.00313	CbGpPWpGaD
Ropivacaine—Rash—Citalopram—alcohol dependence	0.000273	0.00101	CcSEcCtD
Ropivacaine—Dermatitis—Citalopram—alcohol dependence	0.000273	0.00101	CcSEcCtD
Ropivacaine—Headache—Citalopram—alcohol dependence	0.000271	0.001	CcSEcCtD
Ropivacaine—CYP2B6—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000267	0.00305	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—ADH6—alcohol dependence	0.000265	0.00302	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—GRIN2B—alcohol dependence	0.000262	0.003	CbGpPWpGaD
Ropivacaine—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000262	0.00299	CbGpPWpGaD
Ropivacaine—Nausea—Citalopram—alcohol dependence	0.000257	0.000948	CcSEcCtD
Ropivacaine—CYP2B6—Biological oxidations—MAOB—alcohol dependence	0.000253	0.00289	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—GRIN2B—alcohol dependence	0.000251	0.00287	CbGpPWpGaD
Ropivacaine—CYP1A2—Arachidonic acid metabolism—GGT1—alcohol dependence	0.00025	0.00286	CbGpPWpGaD
Ropivacaine—CYP2D6—Biological oxidations—ADH7—alcohol dependence	0.000242	0.00277	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—ADH4—alcohol dependence	0.000242	0.00276	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—GRIN2B—alcohol dependence	0.000241	0.00275	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—GRIN2B—alcohol dependence	0.000241	0.00275	CbGpPWpGaD
Ropivacaine—CYP1A2—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000239	0.00273	CbGpPWpGaD
Ropivacaine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000236	0.00269	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—GRIN2B—alcohol dependence	0.000233	0.00265	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—GRIN2B—alcohol dependence	0.000233	0.00265	CbGpPWpGaD
Ropivacaine—CYP1A2—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000232	0.00265	CbGpPWpGaD
Ropivacaine—CYP2D6—Biological oxidations—GGT2—alcohol dependence	0.000232	0.00265	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—GRIN2B—alcohol dependence	0.000229	0.00262	CbGpPWpGaD
Ropivacaine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000225	0.00257	CbGpPWpGaD
Ropivacaine—CYP3A4—Tryptophan metabolism—CYP2E1—alcohol dependence	0.000225	0.00257	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—ADH1A—alcohol dependence	0.000219	0.0025	CbGpPWpGaD
Ropivacaine—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000217	0.00248	CbGpPWpGaD
Ropivacaine—CYP2B6—Biological oxidations—ALDH2—alcohol dependence	0.000215	0.00246	CbGpPWpGaD
Ropivacaine—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000214	0.00245	CbGpPWpGaD
Ropivacaine—CYP2D6—Biological oxidations—ADH1B—alcohol dependence	0.000213	0.00243	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—ADH7—alcohol dependence	0.000205	0.00234	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—GGT2—alcohol dependence	0.000197	0.00225	CbGpPWpGaD
Ropivacaine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000191	0.00218	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—ADH4—alcohol dependence	0.000186	0.00213	CbGpPWpGaD
Ropivacaine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000185	0.00212	CbGpPWpGaD
Ropivacaine—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000184	0.0021	CbGpPWpGaD
Ropivacaine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000182	0.00208	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—ADH1B—alcohol dependence	0.00018	0.00206	CbGpPWpGaD
Ropivacaine—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000179	0.00205	CbGpPWpGaD
Ropivacaine—CYP2D6—Biological oxidations—MAOB—alcohol dependence	0.000176	0.00201	CbGpPWpGaD
Ropivacaine—CYP2B6—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000174	0.00198	CbGpPWpGaD
Ropivacaine—CYP2B6—Biological oxidations—CYP2E1—alcohol dependence	0.000172	0.00197	CbGpPWpGaD
Ropivacaine—CYP2B6—Metapathway biotransformation—CYP2E1—alcohol dependence	0.00017	0.00194	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—GRIN2B—alcohol dependence	0.000163	0.00187	CbGpPWpGaD
Ropivacaine—CYP1A2—Phase II conjugation—GGT1—alcohol dependence	0.000159	0.00182	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—ADH7—alcohol dependence	0.000159	0.00181	CbGpPWpGaD
Ropivacaine—CYP2B6—Biological oxidations—GGT1—alcohol dependence	0.000158	0.00181	CbGpPWpGaD
Ropivacaine—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000157	0.00179	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—GGT2—alcohol dependence	0.000152	0.00173	CbGpPWpGaD
Ropivacaine—CYP2D6—Biological oxidations—ALDH2—alcohol dependence	0.00015	0.00171	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—MAOB—alcohol dependence	0.000149	0.0017	CbGpPWpGaD
Ropivacaine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000149	0.0017	CbGpPWpGaD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—EP300—alcohol dependence	0.000148	0.00169	CbGpPWpGaD
Ropivacaine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000147	0.00168	CbGpPWpGaD
Ropivacaine—CYP2B6—Biological oxidations—MAOA—alcohol dependence	0.000142	0.00162	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—ADH1B—alcohol dependence	0.000139	0.00159	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—ALDH2—alcohol dependence	0.000127	0.00145	CbGpPWpGaD
Ropivacaine—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000126	0.00144	CbGpPWpGaD
Ropivacaine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000121	0.00138	CbGpPWpGaD
Ropivacaine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000121	0.00138	CbGpPWpGaD
Ropivacaine—CYP2D6—Biological oxidations—CYP2E1—alcohol dependence	0.00012	0.00137	CbGpPWpGaD
Ropivacaine—CYP2D6—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000118	0.00135	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—EP300—alcohol dependence	0.000117	0.00133	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—MAOB—alcohol dependence	0.000115	0.00131	CbGpPWpGaD
Ropivacaine—CYP2D6—Biological oxidations—GGT1—alcohol dependence	0.00011	0.00125	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—alcohol dependence	0.000104	0.00118	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—alcohol dependence	0.000104	0.00118	CbGpPWpGaD
Ropivacaine—CYP1A2—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000102	0.00117	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—CYP2E1—alcohol dependence	0.000101	0.00116	CbGpPWpGaD
Ropivacaine—CYP1A2—Metapathway biotransformation—CYP2E1—alcohol dependence	0.0001	0.00114	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ADH6—alcohol dependence	9.96e-05	0.00114	CbGpPWpGaD
Ropivacaine—CYP2D6—Biological oxidations—MAOA—alcohol dependence	9.85e-05	0.00112	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—ALDH2—alcohol dependence	9.79e-05	0.00112	CbGpPWpGaD
Ropivacaine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	9.74e-05	0.00111	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—EP300—alcohol dependence	9.43e-05	0.00108	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—GGT1—alcohol dependence	9.31e-05	0.00106	CbGpPWpGaD
Ropivacaine—CYP2B6—Biological oxidations—POMC—alcohol dependence	9.23e-05	0.00105	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—EP300—alcohol dependence	9.02e-05	0.00103	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—EP300—alcohol dependence	8.67e-05	0.000989	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—EP300—alcohol dependence	8.67e-05	0.000989	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—EP300—alcohol dependence	8.36e-05	0.000954	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—EP300—alcohol dependence	8.36e-05	0.000954	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—MAOA—alcohol dependence	8.35e-05	0.000953	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ADH1A—alcohol dependence	8.25e-05	0.000942	CbGpPWpGaD
Ropivacaine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	7.89e-05	0.000901	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—CYP2E1—alcohol dependence	7.83e-05	0.000894	CbGpPWpGaD
Ropivacaine—CYP3A4—Metapathway biotransformation—CYP2E1—alcohol dependence	7.72e-05	0.000881	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—GGT1—alcohol dependence	7.19e-05	0.000821	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ADH4—alcohol dependence	7.02e-05	0.000801	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ADH6—alcohol dependence	6.92e-05	0.00079	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—MAOA—alcohol dependence	6.44e-05	0.000735	CbGpPWpGaD
Ropivacaine—CYP2D6—Biological oxidations—POMC—alcohol dependence	6.41e-05	0.000732	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ADH7—alcohol dependence	5.97e-05	0.000681	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—EP300—alcohol dependence	5.87e-05	0.000671	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ADH6—alcohol dependence	5.86e-05	0.000669	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ADH1A—alcohol dependence	5.73e-05	0.000655	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GGT2—alcohol dependence	5.72e-05	0.000653	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—POMC—alcohol dependence	5.43e-05	0.00062	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ADH1B—alcohol dependence	5.23e-05	0.000597	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ADH4—alcohol dependence	4.88e-05	0.000557	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ADH1A—alcohol dependence	4.86e-05	0.000555	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ADH6—alcohol dependence	4.52e-05	0.000517	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—MAOB—alcohol dependence	4.33e-05	0.000495	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—POMC—alcohol dependence	4.19e-05	0.000479	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ADH7—alcohol dependence	4.15e-05	0.000473	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ADH4—alcohol dependence	4.13e-05	0.000472	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GGT2—alcohol dependence	3.97e-05	0.000454	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ADH1A—alcohol dependence	3.75e-05	0.000428	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ALDH2—alcohol dependence	3.69e-05	0.000421	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ADH1B—alcohol dependence	3.64e-05	0.000415	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	3.58e-05	0.000408	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ADH7—alcohol dependence	3.51e-05	0.000401	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GGT2—alcohol dependence	3.37e-05	0.000384	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ADH4—alcohol dependence	3.19e-05	0.000364	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GOT2—alcohol dependence	3.13e-05	0.000358	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ADH1B—alcohol dependence	3.08e-05	0.000352	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—MAOB—alcohol dependence	3.01e-05	0.000344	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CYP2E1—alcohol dependence	2.95e-05	0.000336	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ADH7—alcohol dependence	2.71e-05	0.000309	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GGT1—alcohol dependence	2.7e-05	0.000309	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GOT1—alcohol dependence	2.7e-05	0.000309	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GGT2—alcohol dependence	2.6e-05	0.000297	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ALDH2—alcohol dependence	2.56e-05	0.000292	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—MAOB—alcohol dependence	2.55e-05	0.000291	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—MAOA—alcohol dependence	2.42e-05	0.000277	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ADH1B—alcohol dependence	2.38e-05	0.000271	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GOT2—alcohol dependence	2.18e-05	0.000249	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ALDH2—alcohol dependence	2.17e-05	0.000248	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	2.09e-05	0.000238	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CYP2E1—alcohol dependence	2.05e-05	0.000234	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—MAOB—alcohol dependence	1.97e-05	0.000225	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GGT1—alcohol dependence	1.88e-05	0.000215	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GOT1—alcohol dependence	1.88e-05	0.000215	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GOT2—alcohol dependence	1.84e-05	0.000211	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CYP2E1—alcohol dependence	1.73e-05	0.000198	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—MAOA—alcohol dependence	1.68e-05	0.000192	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ALDH2—alcohol dependence	1.67e-05	0.000191	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GOT1—alcohol dependence	1.59e-05	0.000182	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GGT1—alcohol dependence	1.59e-05	0.000182	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—POMC—alcohol dependence	1.58e-05	0.00018	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—MAOA—alcohol dependence	1.43e-05	0.000163	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GOT2—alcohol dependence	1.42e-05	0.000163	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	1.38e-05	0.000158	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CYP2E1—alcohol dependence	1.34e-05	0.000153	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GOT1—alcohol dependence	1.23e-05	0.00014	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GGT1—alcohol dependence	1.23e-05	0.00014	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—MAOA—alcohol dependence	1.1e-05	0.000126	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—POMC—alcohol dependence	1.1e-05	0.000125	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—EP300—alcohol dependence	1.05e-05	0.00012	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—POMC—alcohol dependence	9.29e-06	0.000106	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—EP300—alcohol dependence	7.28e-06	8.31e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—POMC—alcohol dependence	7.17e-06	8.19e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—EP300—alcohol dependence	6.16e-06	7.04e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—EP300—alcohol dependence	4.76e-06	5.43e-05	CbGpPWpGaD
